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RABIES
Rabies is a fatal disease and represents a severe public health problem in
developing countries.
Without treatment, rabies infection of humans is almost invariably fatal.
The World Health Organization estimates 40.000-70.000 deaths of rabies every
year.
Schnell et al.. (2010)
RABIES
Prevention of rabies in humans depends on a combination of interventions,
including :
Pre-exposure immunization of people at frequent risk of exposure
Provision of post-exposure prophylaxis to potentially exposed patients
There is a need to develop safer, cheaper and efficacious vaccine against rabies...
RABIES VIRUS (RV)
Enveloped virus of the Rhabdoviridae family
Released from the infected cell by budding 
Negative-stranded RNA virus
Encodes 5 structural proteins of which
Matrix protein (M2)
Glycoprotein (G)
Central role in virus budding during virus infection
(Adapted from Schnell et al., 2010) 
Glycoprotein (G)
It is an integral transmembrane protein
Organized as a trimer in the virus surface
It is the major viral antigen responsible for the induction 
of protective immunity
Induce T helper cells   (Celis et al., 1986)
Induce cytotoxic T cells   (Mcfarlane et al., 1986)
Production virus neutralizing antibodies   (Perrin et al., 1985) 
G protein posseses an autonomous exocytosis activity
Infectious particles containing G protein were found in the supernatants of 
infected cells (Mebatsion et al., 1996)
Objectives
Construct a VLP expressing in HEK293 cells the rabies virus
G protein
 Construct a recombinant cell line that expresses the G protein and
evaluate the particle production
 Express the matrix protein together with the glycoprotein to evaluate
whether the presence of this protein improves particle budding
 Immunize mice with the VLPs and evaluate the immune response
triggered















pMDL, pREV, pMD2.G (Dull et al., 1998; Segall et al. 2003) 
pLV-PLK (Prieto et al., 2011)
Lentivirus Titer 
(Lentivirus-Associated HIV p24)
 LV-G: 5x107 LP/ml
 LV-M2: 7x107 LP/ml
G protein (PV strain)
M2 protein (PV strain)
Recombinant cell line development
HEK293 cells
Lentiviral vector-mediated transduction




G and M2 expressing 
cell line (HEK-G/M2)LV-M2
Recombinant cell line development
 Analysis of the G protein expression
HEK-G HEK-G/M2
Flow cytometry





• Goat anti-mouse AlexaFluor 488
Fluorescense microscopy
• mAb against G protein
• Goat anti-mouse AlexaFluor 488
cells cells
Recombinant cell line development























































1E-4 1E-3 0,01 0,1 1 10
0,2
Dilutions






89   kDa
32   kDa




 Testing for Replication Competent Lentivirus (RCL)
RCL?
 p24 ELISA to detect HIV-1 capsid protein (GAG)
HEK-G
RCL assay
 Testing for Replication Competent Lentivirus (RCL)

 p24 ELISA to detect HIV-1 capsid protein (GAG)
HEK-G
Immunization protocol 
 Female Balb/c mice
 Intramuscular route
 Freud incomplete adyuvant
 2 dosis (0 and 12 day)
 Four groups:
A. Commercial human vaccine - VERORAB (n=4)
B. Commercial animal vaccine - BAGOVAC (n=4)
C. 0.3 µg of VLPs (n=5)
D. 3 µg of VLPs (n=5)
 Blood samples collected on day 19
 Analyzed by flow cytometry
Immunization protocol 
“TARGET CELLS FOR ANTIBODIES DETECTION IN 
RABIES VACCINE CONTROL”
















































 0.3 ug VLPs
 3 ug VLPs
 Sera analysis























 We constructed two recombinant cell lines
 HEK-G
 HEK-G/M2
 We confirmed the expression of RV proteins by flow cytometry, fluorescence
microscopy, RT-PCR and western blot.
 The co-expression of the M2 protein, in this case, does not increase the
amount of VLPs in the supernatant
 VLPs concentrated by ultracentrifugation were analyzed by TEM
Conclusion…
 We immunized Balb/c mice with VLPs preparations and we compared it with
commercial vaccines
 The collected blood samples were analyzed by flow cytometry
 The results obtained indicate that this VLPs are immunogenic and capable of
inducing specific antibody responses
 With these results, and with further analysis, these virus-like particles could
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